Oncolytics Biotech Reports Data in Colorectal Cancer Study
By Karen Roman Oncolytics Biotech Inc. (Nasdaq: ONCY) said it has new data showing the use of pelareorep in metastatic colorectal cancer has a 19.5-month median...
Veterans in Finance: Roberts & Ryan Senior Director Pete Clarke, Live from Nasdaq
IPO Edge hosted a fireside chat on March 24 at Nasdaq MarketSite with Pete Clarke,...
Golden Matrix Doubles Down on Profitability Amid Record FY Revenue
Global gaming operator Golden Matrix Group, Inc. (NASDAQ: GMGI) reported Q4 Revenue Rose 81% to...
IPO Edge to Attend Centri Capital Conference at Nasdaq on April 22
IPO Edge will be onsite in New York for Centri Business Consulting’s inaugural Centri Capital...
Life-Saving Drugs Hiding in Plain Sight: LifeMine Therapeutics CEO Greg Verdine, Live at NYSE
IPO Edge hosted a fireside chat on Feb. 13 from the floor of the New...
Wall Street Heads to Texas: Vinson & Elkins Partner Ben Heriaud, Live from NYSE
IPO Edge hosted a fireside chat on Feb. 13 from the floor of the New...
Institutional Love for Crypto: Blockchain.com President Lane Kasselman, Live from NYSE
IPO Edge hosted a fireside chat on Feb. 13 from the floor of the New...
Cutting-Edge Travel Tech: Yanolja Cloud CEO Jeff Kim, Live from NYSE
IPO Edge hosted a fireside chat on Feb. 13 from the floor of the New...
